Dacihep contains Daclatasvir as an active agent and it is used to treat patients with chronic (long-lasting) hepatitis C virus (HCV) infection. Dacihep (Daclatasvir) is available in the form of tablets and strength of 60mg. This tablet works by decreasing the amount of virus from the body and make the immune system work better. Use of Dacihep tablets is not recommended in patients under the age of 18. Monitoring of liver and kidney function is required during treatment with this effective regimen.